Who is sponsoring NCT05344326?

NCT05344326 is sponsored by University of Sheffield.

What drugs are being tested in NCT05344326?

Interventions in NCT05344326: Cognitive Analytic Therapy - Guided Self Help (CAT-GSH).

What condition does NCT05344326 study?

NCT05344326 studies Depression.

Is NCT05344326 still recruiting?

NCT05344326 is currently status unknown. Last updated 6 December 2023.

Last reviewed 2023-12-06 · How we verify

NCT05344326

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cognitive Analytic-Informed Guided Self-help for Depression

Status unknown NA Last updated 6 December 2023

What this trial tests

NA trial testing Cognitive Analytic Therapy - Guided Self Help (CAT-GSH) in Depression in 13 participants. Status unknown.

Timeline

7 November 2022

Primary endpoint
31 May 2024

31 May 2024

Quick facts

Lead sponsor	University of Sheffield
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	13
Start date	7 November 2022
Primary completion	31 May 2024
Estimated completion	31 May 2024
Sites	1 location across United Kingdom

Drugs / interventions tested

Cognitive Analytic Therapy - Guided Self Help (CAT-GSH)

Conditions studied

Depression — all drugs for Depression →

Sponsor

University of Sheffield

Who can join

Adults 18 to 65, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cognitive analytic therapy (CAT) is used within mental health services as a treatment for a range of mental health difficulties. Recent research has adapted CAT to be used as guided self-help for anxiety within Increasing Access to Psychological Therapies (IAPT). IAPT is a mental health service. Guided self help-CAT (CAT-GSH) is delivered by mental health professionals called Psychological Wellbeing Practitioners (PWPs). This current study aims to develop and pilot a CAT-GSH manual for depression for use in the same context and practitioners. Stage one uses past research and consultation meetings to help develop the treatment. Stage two will use different approaches to explore the acceptability and outcomes of the intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other University of Sheffield trials

Trials by the same sponsor.

NCT07049042 — Hypogonadotrophic Hypogonadism in Genetic Neurodevelopmental Conditions · recruiting
NCT07132879 — Telehealth in MND-Research (TIM-R): A Research Database for MND · recruiting
NCT06628427 — Unlock the Secrets of Ageing Brains Through P300 Brain-computer Interface Games · not yet recruiting
NCT06476483 — Feasibility and Acceptability of Implementing DIALOG+ in a Psychiatric Rehabilitation Unit · NA · completed
NCT06508840 — The Clear Conversations Project · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05344326 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Sheffield
Last refreshed: 6 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05344326.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing